Key result
Off-pump CABG cuts acute kidney injury ~13% without improving early mortality or stroke vs. on-pump.
Why the study?
This study aimed to compare perioperative and long-term outcomes of off-pump versus on-pump coronary artery bypass grafting by analysing randomised and observational evidence separately, as these designs differ in their susceptibility to confounding and selection bias.
Does off-pump coronary artery bypass grafting (OPCAB) improve perioperative and long-term clinical outcomes compared to on-pump coronary artery bypass grafting (ONCAB) in patients undergoing isolated CABG?
Meta-Analysis (n=196,663)
Yes
Does off-pump coronary artery bypass grafting (OPCAB) improve perioperative and long-term clinical outcomes compared to on-pump coronary artery bypass grafting (ONCAB) in patients undergoing isolated CABG?
Off-pump CABG offers selective perioperative benefits by reducing acute kidney injury and blood transfusion requirements without altering early mortality, stroke, or long-term survival compared to on-pump CABG.
Answers are grounded in this paper and cite their sources.
Off-pump CABG reduces acute kidney injury without increasing long-term mortality; confirms survival equivalence to on-pump in randomized evidence.
Objective To compare perioperative and long-term outcomes of off-pump (OPCAB) vs on-pump (ONCAB) coronary artery bypass grafting, analysing randomised and observational evidence separately. Methods PubMed/MEDLINE, Scopus and the Cochrane Library were searched till 31 July 2026 for randomised controlled trials (RCTs) and comparative observational studies of isolated CABG. Random-effects meta-analyses were performed in RevMan 5.4. Procedural characteristics were also systematically evaluated. Results A total of 38 reports representing 30 independent studies (16 RCTs and 14 observational cohorts; 196,663 participants) were included. In RCTs, OPCAB reduced acute kidney injury (RR 0.87, 95% CI = 0.80–0.95) and blood transfusion (RR 0.72), but showed no significant benefit for early mortality, stroke, myocardial infarction, dialysis, reoperation for bleeding or intensive care unit stay. Long-term mortality was similar in RCTs (RR 1.05, 95% CI = 0.98–1.12) and observational studies reporting adjusted estimates (HR 1.02, 95% CI = 0.95–1.09). Observational evidence favoured OPCAB for early mortality and stroke but remained susceptible to residual confounding. Conclusions OPCAB provides selective perioperative benefits without improving long-term survival. Its effectiveness depends on complete, technically durable revascularisation and appropriate surgical expertise.
No takes yet. Share an insight, caveat, or question.
Kaçani et al. (2026) conducted a meta-analysis in Coronary artery disease undergoing isolated coronary artery bypass grafting (CABG) (n=196,663). Off-pump coronary artery bypass grafting (OPCAB) vs. On-pump coronary artery bypass grafting (ONCAB) was evaluated on Early mortality and postoperative stroke (with key pooled survival reported for long-term mortality in RCTs) (RR 1.05, 95% CI 0.98–1.12). Off-pump CABG reduced acute kidney injury and blood transfusion in RCTs without improving early mortality, stroke, or long-term survival.
Synapse has enriched 10 related papers. Consider them for comparative context: